The findings add further fuel to expand access to psychedelics as a form of treatment for depression and a host of other mental health disorders.
A London biotech startup announced Wednesday that it had found success in treating major depressive disorder with intravenous DMT in a clinical trial. Though follow-up trials will be necessary to further prove out the drug’s efficacy, the findings add further fuel to the push to expand access to pDMT, the acronym for N,N-Dimethyltryptamine, is best known as a psychedelic drug that elicits a very rapid, very intense, and relatively short duration of hallucinogenic effects .
“I’m delighted by our short term results,” George Tziras, the CEO of Small Pharma, said on a conference call announcing the findings Wednesday. “With these results, we feel confident with moving forward with our SPL026 program.” As part of the study’s first arm, Small Pharma’s researchers found that patients who received SPL026 followed by supportive therapy found a 10.8 point difference in reduction in depression symptoms on the MADRS scale one week after the initial dose, compared to those who received the placebo. After two weeks, the MADRS score difference was 7.4—a small shrink, but still high.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Column: Local biotech leader promotes STEM careers for minoritiesEntrepreneur Bill Rastetter co-founded and chairs a nonprofit that encourages STEM training and careers for students in underserved local communities
Lire la suite »
Microsoft invests billions in artificial intelligence startup OpenAIThe tech giant described its new agreement as the third stage of a growing partnership with San Francisco-based OpenAI that began with a $1 billion investment in 2019.
Lire la suite »
WSJ News Exclusive | Rivian’s Chief Lobbyist Is Leaving the EV StartupRivian Automotive's chief lobbyist, Jim Chen, is departing the company, the latest high-level exit as the electric-vehicle startup works to scale up operations
Lire la suite »
This Startup Is Using AI to Unearth New SmellsThe $30 billion global fragrance industry relies on raw ingredients that are becoming increasingly difficult or controversial to source. Osmo hopes to sniff out safe alternatives that are sustainable and that don't require harvesting from the ecosystem.
Lire la suite »
Asteroid mining startup AstroForge to launch first space missions this yearAsteroid-mining startup AstroForge Inc. plans to launch its first two missions to space this year as it seeks to extract and refine metals from deep space.
Lire la suite »
Startup Predicts Year That Technological Singularity Will HappenItalian AI scientists have come up with a unique means of measuring how far away we are from technological singularity. By their data, we're not far off.
Lire la suite »